Site navigation

Navigation

Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease

 
Guidance issued
 
Number: IPG222

Summary

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease.

Description

An overtube and implant delivery mechanism is endoscopically guided to the gastro-oesophageal junction. Suction is applied to pull a fold of the oesophageal wall into the overtube. Saline is injected into this fold to create a space within the submucosa, and one or more hydrogel prostheses are implanted. The prostheses absorb water and expand to create a fold in the oesophageal wall bulking the oesophagus and preventing gastro-oesophageal reflux.

OPCS code:

Details

Arrangement:
Special
Topic area:
Digestive system
Surgical procedures
Specialty:
Gastroenterology
Specialist advice has been sought from:

Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland

British Society of Gastroenterology

Date notified to NICE:
27 June 2003
Provisional consultation date:
Winter/Spring 2007
Guidance issue date:
27 June 2007

Contact details:

Project manager (for general enquiries or comments)
(for general enquiries or comments)
Ben Doak
Technical lead
(for procedure specific enquiries or comments)
Sally Hamilton
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA

Links: